Zobrazeno 1 - 10
of 160
pro vyhledávání: '"ABCC5"'
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Over 90% of treatment failures in cancer therapy can be attributed to multidrug resistance (MDR), which can develop intracellularly or through various routes. Numerous pathways contribute to treatment resistance in cancer, but one of the most signifi
Externí odkaz:
https://doaj.org/article/0c84e1f4353a4a2689aee02b6a499016
Autor:
Lin He, Hengjun Qian, Ayinuer seyiti, Chengshaoxiong Yang, Ning Shi, Chen Chen, Pingxu Zhang, Youxiang Hou
Publikováno v:
Heliyon, Vol 10, Iss 17, Pp e37066- (2024)
Objective: This study explores the correlation between Forkhead box M1 (FOXM1) and ATP-binding cassette subfamily C member 5 (ABCC5) in relation to paclitaxel resistance in cervical cancer. It aims to identify potential cervical cancer stem cell mark
Externí odkaz:
https://doaj.org/article/647f56c92fab45a89ef85f4f996b3198
Autor:
Wenbin Huang, Kunling Chen, Yishi Lu, Donghui Zhang, Yuan Cheng, Liuran Li, Weimei Huang, Guolin He, Hangyu Liao, Lei Cai, Yujun Tang, Liang Zhao, Mingxin Pan
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 12, Pp 1227-1239 (2021)
Sorafenib is a first-line molecular-target drug for advanced hepatocellular carcinoma (HCC), and reducing sorafenib resistance is an important issue to be resolved for the clinical treatment of HCC. In the current study, we identified that ABCC5 is a
Externí odkaz:
https://doaj.org/article/7fc3e1c3b68146b586da3b4215746095
Publikováno v:
International Journal of General Medicine, Vol Volume 14, Pp 7235-7246 (2021)
Yuting Qiu,1,* Haobo Li,2,* Jiaheng Xie,3 Xinwei Qiao,1 Jing Wu1 1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Centre for Digestive Diseases, Beijing, 100050, People’s R
Externí odkaz:
https://doaj.org/article/fe343c85cac1438590788c4313034d98
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundNon-alcoholic fatty liver disease (NAFLD) is a risk factor for hepatocellular carcinoma (HCC). However, its carcinogenic mechanism is still unclear, looking for both diseases’ transcriptome levels, the same changes as we are looking for N
Externí odkaz:
https://doaj.org/article/7c5e7d9a8e6644dfb6ac5c49ea81b3e2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jansen, Robert S., Addie, Ruben, Merkx, Remco, Fish, Alexander, Mahakena, Sunny, Bleijerveld, Onno B., Altelaar, Maarten, IJlst, Lodewijk, Wanders, Ronald J., Borst, P., van de Wetering, Koen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2015 May . 112(21), 6601-6606.
Externí odkaz:
https://www.jstor.org/stable/26463395
Autor:
Zhonghua Yang, Yuan Cao, Li Hu, Yiming Hu, Dan Wu, Liang Chen, Jiaheng Xie, Wei Bao, Hongzhu Yu
Publikováno v:
Channels
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. Many patients with hepatocellular carcinoma are diagnosed at an advanced stage because the early symptoms are not obvious. For advanced hepatocellular carcinoma, immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7f4fb14e8e558ead23c87266636a164
http://europepmc.org/articles/PMC8437464
http://europepmc.org/articles/PMC8437464
Autor:
Daniel Sinnett, Gregor Andelfinger, Simon Drouin, Yutaka Yasui, Fan Wang, Mathilde Le Guern, Patrick Beaulieu, Pascal St-Onge, Aziz Rezgui, Laurence Bertout, Maja Krajinovic, Marie-Josée Raboisson, Kateryna Petrykey, Caroline Laverdière, Melissa M. Hudson, Jessica L Baedke
Publikováno v:
Pharmacogenomics
Aim: Cardiovascular disease represents one of the main causes of secondary morbidity and mortality in patients with childhood cancer. Patients & methods: To further address this issue, we analyzed cardiovascular complications in relation to common an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e612e577eb726e27d5e578f3f83a570
https://doi.org/10.2217/pgs-2021-0067
https://doi.org/10.2217/pgs-2021-0067